Amir Bar‐Shai

937 total citations
56 papers, 443 citations indexed

About

Amir Bar‐Shai is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Infectious Diseases. According to data from OpenAlex, Amir Bar‐Shai has authored 56 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 7 papers in Infectious Diseases. Recurrent topics in Amir Bar‐Shai's work include Chronic Obstructive Pulmonary Disease (COPD) Research (21 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers) and Respiratory Support and Mechanisms (7 papers). Amir Bar‐Shai is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (21 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers) and Respiratory Support and Mechanisms (7 papers). Amir Bar‐Shai collaborates with scholars based in Israel, United States and Switzerland. Amir Bar‐Shai's co-authors include Ophir Freund, Galit Aviram, Arie Steinvil, Ofer Zimmerman, Galia Rosen, Ori Rogowski, Jacob Sosna, Shani Shenhar‐Tsarfaty, Yehuda Schwarz and R. Alon and has published in prestigious journals such as PLoS ONE, Radiology and The FASEB Journal.

In The Last Decade

Amir Bar‐Shai

49 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amir Bar‐Shai Israel 11 180 99 92 77 57 56 443
Matthew C. Madison United States 10 179 1.0× 119 1.2× 57 0.6× 215 2.8× 86 1.5× 16 529
Andrea Vukić Dugac Croatia 10 164 0.9× 93 0.9× 28 0.3× 47 0.6× 39 0.7× 50 319
Hongyang Xu China 11 126 0.7× 96 1.0× 38 0.4× 48 0.6× 31 0.5× 34 422
Maiko Kadowaki Japan 11 169 0.9× 78 0.8× 79 0.9× 47 0.6× 16 0.3× 19 346
Choonghyun Ahn South Korea 13 91 0.5× 54 0.5× 82 0.9× 34 0.4× 20 0.4× 18 404
Yuichi Adachi Japan 12 162 0.9× 98 1.0× 54 0.6× 43 0.6× 27 0.5× 58 473
Loubna Akhabir Canada 12 142 0.8× 167 1.7× 44 0.5× 222 2.9× 139 2.4× 19 540
Qun Luo China 9 110 0.6× 85 0.9× 70 0.8× 73 0.9× 21 0.4× 25 292
Sabrina Mellino Italy 8 138 0.8× 41 0.4× 46 0.5× 54 0.7× 34 0.6× 14 295
Hataya Poonyagariyagorn United States 8 489 2.7× 58 0.6× 92 1.0× 194 2.5× 27 0.5× 10 650

Countries citing papers authored by Amir Bar‐Shai

Since Specialization
Citations

This map shows the geographic impact of Amir Bar‐Shai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Bar‐Shai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Bar‐Shai more than expected).

Fields of papers citing papers by Amir Bar‐Shai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amir Bar‐Shai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Bar‐Shai. The network helps show where Amir Bar‐Shai may publish in the future.

Co-authorship network of co-authors of Amir Bar‐Shai

This figure shows the co-authorship network connecting the top 25 collaborators of Amir Bar‐Shai. A scholar is included among the top collaborators of Amir Bar‐Shai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir Bar‐Shai. Amir Bar‐Shai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freund, Ophir, et al.. (2025). Real-World Experience of Dupilumab Treatment for Patients with COPD – A Single Center Prospective Study. International Journal of COPD. Volume 20. 2753–2760.
2.
Freund, Ophir, Anne Bergeron, Andrew Shaffer, et al.. (2025). Bronchiectasis after allogeneic hematopoietic cell transplantation – an underdiagnosed complication. Respiratory Medicine. 245. 108208–108208. 1 indexed citations
3.
Freund, Ophir, Amir Bar‐Shai, Cole D. Bendor, et al.. (2025). High rate of immediate and early post-traumatic venous thromboembolism in combat soldiers. Thrombosis Research. 252. 109382–109382.
4.
Freund, Ophir, Amir Bar‐Shai, Ariel Banai, et al.. (2024). Smoking and Respiratory Diseases in Patients with Coronary Microvascular Dysfunction. The American Journal of Medicine. 137(6). 538–544.e1. 7 indexed citations
5.
Gershman, Evgeni, et al.. (2024). Cytokine fingerprint differences following infection and vaccination – what can we learn from COVID-19?. European Cytokine Network. 35(1). 13–19. 3 indexed citations
6.
Freund, Ophir, et al.. (2024). Impulse Oscillometry as an Alternative Lung Function Test for Hospitalized Adults. Respiratory Care. 69(4). 415–421. 5 indexed citations
7.
8.
Freund, Ophir, et al.. (2023). Assessment of a close respiratory follow-up schedule at 3 and 6 months after acute COVID-19 and its related investigations. Respiratory Medicine. 217. 107367–107367. 10 indexed citations
9.
Bar‐Shai, Amir, Ophir Freund, Tal Cohen, et al.. (2023). Management of acute COPD exacerbations in the internal medicine departments in Israel–a national survey. Frontiers in Medicine. 10. 1174148–1174148. 8 indexed citations
10.
Freund, Ophir, et al.. (2023). The humoral response to COVID-19 vaccinations can predict the booster effect on health care workers—toward personalized vaccinations?. Journal of Public Health. 46(1). e78–e83. 1 indexed citations
11.
Freund, Ophir, Tamar Shalmon, Ori Wand, et al.. (2023). Real-Life Diagnostic Performance of the Hypersensitivity Pneumonitis Guidelines: A Multicenter Cohort Study. Diagnostics. 13(14). 2335–2335. 3 indexed citations
12.
Freund, Ophir, et al.. (2023). Interactions and clinical implications of serological and respiratory variables 3 months after acute COVID-19. Clinical and Experimental Medicine. 23(7). 3729–3736. 9 indexed citations
13.
Freund, Ophir, et al.. (2022). Importance of physician history taking in complementing patient-reported interstitial lung disease questionnaire. BMC Pulmonary Medicine. 22(1). 489–489. 8 indexed citations
14.
Zeltser, David, Itzhak Shapira, Shlomo Berliner, et al.. (2019). Lung function deterioration predicts elevated troponin levels in apparently healthy individuals throughout a 5-year follow-up. Respiratory Medicine. 154. 63–68. 1 indexed citations
15.
Bar‐Shai, Amir, et al.. (2018). A novel combined score of biomarkers in sputum may be an indicator for lung cancer: A pilot study. Clinica Chimica Acta. 487. 139–144. 3 indexed citations
16.
Bar‐Shai, Amir, Yifat Alcalay, Adi Sagiv, et al.. (2015). Fingerprint of Lung Fluid Ultrafine Particles, a Novel Marker of Acute Lung Inflammation. Respiration. 90(1). 74–84. 7 indexed citations
17.
Weiss, Ido D., Ezra Ella, Yoav Smith, et al.. (2015). In the Hunt for Therapeutic Targets: Mimicking the Growth, Metastasis, and Stromal Associations of Early-Stage Lung Cancer Using a Novel Orthotopic Animal Model. Journal of Thoracic Oncology. 10(1). 46–58. 15 indexed citations
18.
Bar‐Shai, Amir, Adi Sagiv, R. Alon, & Valery Krizhanovsky. (2014). The role of Clara cell senescence in the pathogenesis of COPD. European Respiratory Journal. 44(Suppl 58). 3245–3245. 6 indexed citations
19.
Bar‐Shai, Amir, et al.. (2012). Continued progression of asbestos-related respiratory disease after more than 15 years of non-exposure.. PubMed. 14(9). 560–5. 6 indexed citations
20.
Aviram, Galit, Amir Bar‐Shai, Jacob Sosna, et al.. (2010). H1N1 Influenza: Initial Chest Radiographic Findings in Helping Predict Patient Outcome. Radiology. 255(1). 252–259. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew C. Madison Breakdown of academic impact, for papers by Andrea Vukić Dugac Breakdown of academic impact, for papers by Hongyang Xu Breakdown of academic impact, for papers by Maiko Kadowaki Breakdown of academic impact, for papers by Choonghyun Ahn Breakdown of academic impact, for papers by Yuichi Adachi Breakdown of academic impact, for papers by Loubna Akhabir Breakdown of academic impact, for papers by Qun Luo Breakdown of academic impact, for papers by Sabrina Mellino Breakdown of academic impact, for papers by Hataya Poonyagariyagorn
Rankless by CCL
2026